The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and prognosis in inoperable stage III NSCLC after concurrent chemoradiotherapy with or without immune checkpoint inhibition: Historical overview.
 
Benedikt Flörsch
No Relationships to Disclose
 
Julian Taugner
No Relationships to Disclose
 
Lukas Käsmann
No Relationships to Disclose
 
Saskia Kenndoff
No Relationships to Disclose
 
Julian Guggenberger
No Relationships to Disclose
 
Amanda Tufman
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Lilly; MSD; Pfizer; Roche; Takeda
Research Funding - AstraZeneca
 
Niels Reinmuth
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Pfizer; Roche; Takeda
 
Thomas Duell
No Relationships to Disclose
 
Claus Belka
No Relationships to Disclose
 
Chukwuka Eze
No Relationships to Disclose
 
Farkhad Manapov
Honoraria - AstraZeneca; BrainLAB; Elekta
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Elekta
Research Funding - AstraZeneca